计算机认知矫正治疗对不同程度认知功能损害精神分裂症患者的临床效应差异

来源 :中华精神科杂志 | 被引量 : 0次 | 上传用户:mamao844661
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨计算机认知矫正治疗(computerized cognitive remediation therapy, CCRT)对精神分裂症患者认知功能的改善率以及不同程度认知功能损害的患者对CCRT的临床效应差异。方法:采用随机数字表法将311?例精神分裂症患者分成CCRT组(n n=196)和工娱治疗(work and amusement therapy, WAT)组(n n=115),分别给予自主开发的CCRT、操作性音乐和舞蹈治疗12周。在治疗前、后采用精神分裂症认知功能成套测验(MATRICS Consensus Cognitive Battery,MCCB)对患者的认知功能进行评估,按基线时MCCB总分将患者认知功能分为4?个水平:严重认知功能损害、中度认知功能损害、轻度认知功能损害、认知功能正常,根据MCCB总分的变化将患者的疗效分为3?种情况:无改善(≤0?分),改善(0~9.57?分),显著改善(>9.57?分),最后比较2组认知功能改善率的差异。n 结果:CCRT组认知功能显著改善19?例,改善105?例,无改善46?例;WAT组显著改善7?例,改善39?例,无改善41?例。CCRT组认知功能的改善优于WAT组(n Z=2.978, n P=0.003)。CCRT组较WAT组严重认知功能损害的患者有较高的改善率(n Z=1.860,n P=0.032)。CCRT组中度认知功能损害的患者无改善率低于WAT组(n Z=-1.817,n P=0.035)。CCRT组轻度认知功能损害的患者较WAT组无改善率低(n Z=-3.294,n P=0.001),而改善率和显著改善率均升高(n Z=2.084,n P=0.019;n Z=1.969,n P=0.025)。认知功能正常的患者CCRT组与WAT组改善率差异无统计学意义。将改善和显著改善的患者合并统称为有改善后,2组比较结果显示轻度认知功能损害的患者经CCRT后改善率较WAT升高[77.2%(44/57)与41.4%(12/29),χ2=10.853,n P=0.001];而基线时存在严重认知功能损害、中度认知功能损害或认知功能正常的患者,经CCRT后改善率同WAT相比差异均无统计学意义。不同程度认知功能损害患者经CCRT后认知功能改善的等级按照n Cohen′d分别为:轻度认知功能损害(0.59)>中度认知功能损害(0.48)>正常认知功能(-0.12)>重度认知功能损害(-0.24)。n 结论:CCRT对精神分裂症患者认知功能的改善率优于WAT,轻度认知功能损害的患者经CCRT后认知功能改善率更高。“,”Objective:To explore the improvement rate of the cognitive function of computerized cognitive remediation therapy (CCRT) on patients with schizophrenia and the clinical effect of CCRT in patients with different levels of cognitive impairment.Methods:A random number table was used to divide 311 patients with schizophrenia into CCRT group (n n=196) and work and amusement therapy (WAT) group (n n=115). The independently developed CCRT and operational music and dance therapy were given for 12 weeks to two treatment groups respectively. All patients were assessed using the MATRICS Consensus Cognitive Battery (MCCB) before and after treatment. According to the total score of MCCB at baseline, the patient′s cognition function was divided into 4 levels: severe cognitive impairment, moderate cognitive impairment, mild cognitive impairment and normal cognitive function. According to the change of MCCB total score, the efficacy of the treatment was divided into 3 levels: no improvement (≤0 points), improvement (0-9.57 points), superior improvement (>9.57 points). The improvement rate of cognitive function between two treatment groups was compared.n Results:In the CCRT group, there were 19 cases with superior improvement, 105 cases with improvement, and 46 cases with no improvement. In the WAT group, there were 7 cases with superior improvement, 39 cases with improvement, and 41 cases with no improvement. The improvement of cognitive function of CCRT group was better than that of WAT group, and the difference was statistically significant (n Z=2.978, n P=0.003). The patients with serious cognitive impairment in the CCRT group had a higher improvement rate than those in the WAT group (n Z=1.860, n P=0.032). The patients with moderate cognitive impairment in the CCRT group had a lower no improvement rate than those in the WAT (n Z=-1.817, n P=0.035).The patients with mild cognitive impairment in the CCRT group had a lower no improvement rate (n Z=-3.294, n P=0.001) and higher improvement rate and superior improvement rate (n Z=2.084, n P=0.019; n Z=1.969, n P=0.025) than those in the WAT group. There was no statistically significant difference in improvement rate between patients with normal cognitive function in the CCRT group and in the WAT group (n P>0.05).The patients with improvement and superior improvement of cognition were combined as responder, and the two treatment groups were compared. The patients with mild cognitive impairment in the CCRT group had a higher improvement rate than those in the WAT group (77.2%(44/57)n vs. 41.4%(12/29),χ2=10.853,n P=0.001). However, for patients with serious and moderate cognitive impairment or with normal cognitive function at baseline, rates of improvement after treatment did not differ significantly between CCRT group and WAT group. According to n Cohen′s d, the level of effect size in cognition improvement after CCRT treatment in patients with different cognitive dysfunction level was: mild cognitive impairment (0.59)>moderate cognitive impairment (0.48)>normal cognitive function (-0.12)>serious cognitive impairment (-0.24).n Conclusions:Schizophrenic patients treated with CCRT had a higher improvement rate of cognitive function than those with WAT, and the improvement rate of cognitive function is higher in patients with mild cognitive impairment after CCRT treatment.
其他文献
组内分工要明确,人人有事做.如果要让学生的小组合作学习有序、有效地开展,教师就要给学生一个有明确的学习任务或是一个需要解决的问题.
为明确不同烟草品种的耐盐程度、选育出耐盐烟草品种,采用人工气候箱培养,通过主成分分析和聚类分析对不同烟草品种萌发期的耐盐性进行了综合评价.结果表明,盐胁迫导致K326根
有关安乐死的表述多种多样,其要点可以大体归纳为:由于精神和躯体的极端痛苦,经不可治愈的垂危病人本人及其至亲的再三请求,在不违背事件发生地法律的前提下,经谨慎的医学判
期刊
恰逢改革开放40周年,我学医、从医也即将进入第40个年头.真诚地感谢命运,让我在国家蓬勃发展的潮流中实现了自己理想和抱负.时光如白驹过隙,我已为北京大学肿瘤医院服务了22
期刊
在荷兰看急诊rn医生朋友圈子里曾经流传一篇关于美国急诊体验的帖子,里面描述了病人在美国看急诊遇到长时间等待、没有经验的医生以及令人无法接受的高收费等问题,让我想起朋
期刊
肝细胞肝癌(HCC)是常见的恶性肿瘤之一,在世界范围和中国地区发病率居高不下,并呈上升趋势。尤其在中国,其发病率和死亡率长期居于很高水平,对国民生命健康造成了严重的危害,给社会
脑卒中是一种发生机理复杂的疾病,由于脑血流量急剧改变引起多级联病理生理变化,造成机体一系列的代谢紊乱和功能障碍,具有破坏性。脑缺血再灌注损伤指缺血后脑组织细胞损伤,
甲状腺癌发病率惊人上升rn甲状腺癌已经跃居我国女性恶性肿瘤发病率第4位,每年约有15.1万例甲状腺癌患者.我国甲状腺结节病发病率为18.6%,其中单发结节11.6%,多发结节7%.在甲状
期刊
甲状腺癌是内分泌系统最常见的恶性肿瘤,也是头颈部最常见的恶性肿瘤.近年来,在世界范围内,甲状腺癌发病率增长迅速,在我国每年递增约20%.作为一种发病具有明显性别倾向的肿瘤
期刊
情绪波动大的人要当心rn今天我们来谈甲状腺,那么甲状腺长在哪里呢?它位于颈部甲状软骨下方,气管两旁,可随吞咽活动上下移动.具体位置就在喉结下方2~3厘米处,左右两叶,中间部
期刊